Bottom line
Is GVALX a good fund? The bottom line
GVALX is an actively managed large value mutual fund from Fundvantage.
Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 54% of large value funds we track.
It returned +13.9% over one year, +11.4% a year over five years, +11.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $31.6 million in net assets and 275 holdings, its largest position is Lam Research Corp (2.7%) and the top 10 make up 14.5% of the portfolio.
What stands out
- Broadly diversified (275 holdings)
What to watch
- Small fund ($31.6 million) — small funds are likelier to close
- High turnover (2% a year) can mean more taxable distributions
Updated Nov 19, 2026
What GVALX invests in
The Gotham Large Value Fund (the Fund) seeks long-term capital appreciation.
The Fund seeks to achieve its investment objective by investing under normal circumstances in long positions of equity securities. The Fund seeks a total return greater than that of the S&P 500 Index over a full market cycle, which is a period that includes both a bull (rising) market and a bear (falling) market cycle. The Fund will primarily invest in common stocks of U.S. companies listed in the S&P 500 Index, but may invest in other large capitalization companies, primarily selected from the largest 500 700 U.S. companies based on market capitalization. The Fund will generally take long positions in securities that the Adviser believes to be undervalued based on the Advisers analysis of the issuers financial reports and market valuation. The Adviser seeks to capitalize on pricing inefficiencies in the market by employing a systematic, bottom-up, valuation approach based on the…
From the fund's prospectus (filed Jan 28, 2026).
GVALX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GVALX | +13.9% | +11.4% | +11.7% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What GVALX costs
On a $10,000 investment, GVALX's 0.75% expense ratio costs about $75 a year. The prospectus estimates $1,404 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
GVALX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Lam Research Corp LRCX | 2.70% |
| 2 | Caterpillar Inc CAT | 1.72% |
| 3 | Merck & Company Inc MRK | 1.54% |
| 4 | Coca-cola Company (the) KO | 1.32% |
| 5 | Qualcomm Inc QCOM | 1.32% |
| 6 | Pfizer Inc PFE | 1.31% |
| 7 | Altria Group Inc MO | 1.21% |
| 8 | Bristol-myers Squibb Company BMY | 1.15% |
| 9 | Pepsico Inc PEP | 1.10% |
| 10 | Citigroup Inc C | 1.09% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 14.5% of the fund. See all top 25 holdings and asset mix →